Cardiolite
Active substance: tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE 1 mg/mL
United StatesActive
Marketing holder: Lantheus Medical Imaging, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-f219-7519-adf8-b2710d1bc6fb,01a1208f-8bd2-7a32-8aeb-177e06f00a48,01a12090-a8f5-7649-bcc1-812964208189,01a1209c-de8e-7c64-b89e-5e50f0b4aaca;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 11994-001
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 11994-001 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 11994-001 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 11994-001 · Verified 2026-10-09 · open in source